A detailed history of Gts Securities LLC transactions in Incyte Corp stock. As of the latest transaction made, Gts Securities LLC holds 11,800 shares of INCY stock, worth $895,266. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,800
Previous 14,000 15.71%
Holding current value
$895,266
Previous $848,000 8.14%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $347,018 - $415,296
-6,053 Reduced 15.6%
32,742 $2.16 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $1.65 Million - $2.05 Million
32,230 Added 490.94%
38,795 $2.35 Million
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $170,950 - $201,301
3,023 Added 85.35%
6,565 $374,000
Q4 2023

Feb 14, 2024

BUY
$52.16 - $64.19 $184,750 - $227,360
3,542 New
3,542 $222,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.